ArticleJournal of endocrinological investigation2020
Radiofrequency ablation of functioning and non-functioning thyroid nodules: a single institution 12-month survey.
Article in Journal of endocrinological investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Ablative Technologies for Thyroid Nodules: A Health Technology Assessment.Ontario health technology assessment series · 2026Pooled it
- Radioiodine versus radiofrequency ablation to treat autonomously functioning thyroid nodules: a systematic review and comparative meta-analysis.European journal of nuclear medicine and molecular imaging · 2024Pooled it
- Pooled it
- Efficacy and safety of thermal ablation for autonomously functioning thyroid nodules: a systematic review and meta-analysis.European radiology · 2021Pooled it
- Predictors of Initial Response of Thyroid Nodules Treated With RFA, a Multi-Endocrinology Centers Experience From the United States.Journal of the Endocrine Society · 2025Article
- Clinical study on the impact of microwave ablation energy on the treatment efficacy of benign thyroid nodules.Frontiers in oncology · 2025Article
- Radiofrequency ablation as a novel modality in Ecuador for treating toxic thyroid nodules: a case series.Gland surgery · 2024Article
- Efficacy of radiofrequency ablation for treatment of toxic thyroid nodules-a narrative review.Gland surgery · 2024Review
- Clinical efficacy analysis of ultrasound-guided microwave ablation for nodular goiters.American journal of translational research · 2024Article
- Radiofrequency ablation for autonomously functioning nodules as treatment for hyperthyroidism: subgroup analysis of toxic adenoma and multinodular goitre and predictors for treatment success.European journal of nuclear medicine and molecular imaging · 2023Article
- Cost comparison between open thyroid lobectomy and radiofrequency ablation for management of thyroid nodules.Head & neck · 2023Article
- Radiofrequency ablation as a novel modality in the USA for treating toxic thyroid nodules: case series and literature review.Gland surgery · 2022Article
- Nonsurgical Management of Thyroid Nodules: The Role of Ablative Therapies.The Journal of clinical endocrinology and metabolism · 2022Article
- Clinical and functional results of radiofrequency ablation and microwave ablation in patients with benign thyroid nodules.Saudi medical journal · 2021Article
- Safety and Efficacy of Radiofrequency Ablation of Thyroid Nodules-Expanding Treatment Options in the United States.Journal of the Endocrine Society · 2021Article
- [The "hot" thyroid gland carcinoma and a critical look at thermal ablation].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2021Article
- Update of Radiofrequency Ablation for Treating Benign and Malignant Thyroid Nodules. The Future Is Now.Frontiers in endocrinology · 2021Review
- Ultrasound-Guided Thermal Ablation of Thyroid Nodules: Technicalities Progress and Clinical Applications, Especially in Malignant Thyroid Nodules.Frontiers in oncology · 2021Review
- Novel Approaches for Treating Autonomously Functioning Thyroid Nodules.Frontiers in endocrinology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeRadiofrequency (RF) treatment has played an increasing role in the management of benign thyroid nodules in recent years. The aim of this retrospective study was to evaluate the efficacy of RF treatment on volume reduction in functioning and non-functioning thyroid nodules. PATIENTS AND
methodsWe reviewed the medical records of patients who had thyroid nodule RF ablation at our department between August 2017 and May 2018. Patients underwent a periodical follow-up with ultrasound examinations and thyroid function tests at 1, 3, 6 and 12 months from RF. Complications were assessed using the reporting standards of Interventional societies.
results43 patients were submitted to thyroid nodule RF ablation treatment. Patients were subdivided into two groups, those with functioning (17 patients) or non-functioning nodules. At baseline (i.e. pre-RF treatment), the two groups of patients were superimposable for gender, age, BMI, nodule volume and maximum nodule diameter. The volume reduction of all 43 nodules was 69.1 ± 17.3% (range 26.0-94.5%) with no difference between functioning and non-functioning lesions (72.9 ± 18.1% vs 66.7 ± 16.7%, p = 0.254). A total energy delivered per nodule was 16.5 ± 6.8 kJ, with no difference between functioning and non-functioning lesions (14.5 ± 7.2 kJ vs. 18.2 ± 6.3 kJ, p = 0.083, respectively). No major complications were observed.
conclusionsRadiofrequency ablation is a clinically effective and safe outpatient treatment in patients with benign nodules. In particular, we showed that a single treatment is effective in restoring euthyroidism in patients with autonomously functioning thyroid nodules.
Indexed as
Identifiers
31654311What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.